Peter Bentham - Concepedia

Author

Peter Bentham

Birmingham and Solihull Mental Health NHS Foundation Trust ORCID

Also Known As

Bentham, P, P BENTHAM, P Bentham, P. Bentham, P.W. Bentham, PETER W. BENTHAM, Peter Bentham, Peter W Bentham, Peter William Bentham

118

Publications

7.1K

Citations

H-Index

100

Concepts

All Affiliations

Birmingham and Solihull Mental Health NHS Foundation Trust University of Birmingham University of Cambridge King's College London University College London

About

Peter Bentham is an author at Birmingham and Solihull Mental Health NHS Foundation Trust specializing in medicine, alzheimer's disease, and dementia.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	23	2.5K
2	Health Sciences	5	5	214
3	Nursing	3	3	108
4	Engineering	1	1	21
5	Language Studies	1	1	116

Peter Bentham

Publications

Citations

H-Index

Page 1

	Year	Citations
Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial Carol A. Courtney, Dawn Farrell, R. Gray, The Lancet Alzheimer's DiseaseGeriatricsDementiaDouble-blind TrialVascular Dementia	2004	896
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease Robert Howard, Rupert McShane, James Lindesay, New England Journal of Medicine	2012	751
Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial Serge Gauthier, Howard Feldman, Lon S. Schneider, The Lancet Neurodegenerative DiseasesAlzheimer's DiseasePharmacologyClinical TrialsModerate Alzheimer	2016	405
Donepezil for the Treatment of Agitation in Alzheimer's Disease Robert Howard, Edmund Juszczak, Clive Ballard, New England Journal of Medicine	2007	323
Determinants of burden in those who care for someone with dementia Paul Campbell, Jacob Wright, Jan R. Oyebode, International Journal of Geriatric Psychiatry	2008	274
Tau Aggregation Inhibitor Therapy: An Exploratory Phase 2 Study in Mild or Moderate Alzheimer's Disease Claude M. Wischik, Roger T. Staff, Damon Wischik, Journal of Alzheimer s Disease Neurodegenerative DiseasesAlzheimer's DiseaseBiochemistrySelective TaiMedicine	2015	251
Study of the use of antidepressants for depression in dementia: the HTA-SADD trial – a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine Sube Banerjee, Jennifer Hellier, Renée Romeo, Health Technology Assessment	2013	233
Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer’s Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial Gordon Wilcock, Serge Gauthier, Giovanni B. Frisoni, Journal of Alzheimer s Disease	2017	210
EQ-5D in Patients With Dementia An Investigation of Inter-Rater Agreement Wendy Coucill, Stirling Bryan, Peter Bentham, Medical Care	2001	176
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease Robert Howard, Olga Zubko, Rosie Bradley, JAMA Neurology	2019	176

Page 1